Bio-Connect

Goat anti-PNPLA2 / Desnutrin

EB08403
Everest Biotech
ApplicationsImmunoFluorescence, Western Blot, ELISA
Product group Antibodies
TargetPNPLA2
100 ug
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Everest Biotech
  • Product Name
    Goat anti-PNPLA2 / Desnutrin Antibody
  • Delivery Days Customer
    5
  • Application Supplier Note
    Immunofluorescence: This antibody has been successfully used in IF on Human in the following papers, PMID: 33160079.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA
  • Applications Supplier
    Pep-ELISA, WB, IF
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5 mg/ml
  • Gene ID57104
  • Target name
    PNPLA2
  • Target description
    patatin like domain 2, triacylglycerol lipase
  • Target synonyms
    1110001C14Rik, ATGL, FP17548, PEDF-R, TTS-2.2, TTS2, iPLA2zeta, patatin-like phospholipase domain-containing protein 2, IPLA2-zeta, TTS2.2, adipose triglyceride lipase, calcium-independent phospholipase A2, calcium-independent phospholipase A2-zeta, desnutrin, mutant patatin-like phospholipase domain containing 2, patatin like phospholipase domain containing 2, pigment epithelium-derived factor, pigment epithelium-derived factor receptor, transport-secretion protein 2.2, triglyceride hydrolase
  • Host
    Goat
  • Scientific Description
    RefSeq number(s): NP_065109.1. Purification: Antigen affinity purified. Names and symbols: PNPLA2; desnutrin; patatin-like phospholipase domain containing 2; 1110001C14Rik; ATGL; DKFZp667M109; FP17548; PEDF-R; TTS-2.2; TTS2; adipose triglyceride lipase; pigment epithelium-derived factor; transport-secretion protein 2.2; triglyceride hydrolase
  • Reactivity Supplier
    Human, Mouse, Rat, Cow
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Ramseyer VD et al., 2018 Jan, Mol Metab
    Read more